Kaplan Fox & Kilsheimer LLP announced an investigation into potential securities violations against Alignment Healthcare, Inc. On July 8, 2026, a former executive filed a whistleblower complaint alleging accounting irregularities that artificially inflated previously reported and projected financial results, including Adjusted EBITDA, a key non-GAAP metric tied to executive compensation. The complaint claims millions of dollars in operating expenses were systematically misclassified as capital expenditures. Following the news, Alignment Healthcare shares fell $4.02, or 16.7%, to close at $20.03 per share. Kaplan Fox is a nationally recognized plaintiffs' securities litigation firm with a track record of recovering more than $10 billion for clients.
Alignment Healthcare LLCWhistleblower complaint alleges accounting irregularities misclassifying expenses as capex, inflating Adjusted EBITDA; stock fell 16.7%.